Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE000A3CSTW4
Wed, 10.04.2024
VOQUZ Labs AG
Strong momentum as S/4HANA effect should become visible
We hosted a digital roadshow with VOQUZ Labs CEO Martin Kögel, which
provided valuable insights into the investment case. Here are the
takeaways:
Current trading remains on a strong level after we already saw a pick-up in
demand in H2 ’23 (+14% sales vs +3% in H1) as Mr. K&oum [ … ]
Fri, 22.03.2024
VOQUZ Labs AG
Huge potential from promising PwC partnership // chg.
On Wednesday, VOQUZ Labs announced a strategic partnership with PwC
Solutions Germany for the marketing of remQ, the company’s business
transaction monitoring and auditing software for SAP customers. In detail:
PwC will offer its client base in Germany the establishment of a
digitali [ … ]
Thu, 07.03.2024
VOQUZ Labs AG
FY prelims: Strong H2 & promising outlook / chg. est & PT
Topic: VOQUZ Labs announced preliminary FY ’23, indicating a strong
sequential recovery in H2 regarding both, top-line growth and
profitability. Management also issued a promising outlook for the coming
year. In detail:
H2 sales increased by 16% yoy to € 3.4m (eNuW: [ … ]
Wed, 24.01.2024
VOQUZ Labs AG
Reassuring order intake and strong trading momentum
Yesterday, VOQUZ published reassuring 2023 order intake figures, pointing
towards improved operations in the second half of the year.
Total order intake increased by 11.5% yoy to € 5.5m with recurring orders
accounting for a solid 58% (€ 3.2m). The share of product related sales
sl [ … ]
Tue, 21.11.2023
VOQUZ Labs AG
Outlook gets cloudier amid macro-headwinds; chg.
After VOQUZ has shown stellar top-line growth in the past (2019-‘22 CAGR of
38%), the company reported a weak set of H1, clearly reflecting the
deteriorating macro environment.
Despite a 14% yoy increase in order intake, H1 sales only grew by 3% yoy to
€ 1.9m (eNuW: € 2.5m) foll [ … ]